Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • GNRH Receptor
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

ly-202769

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Zoptarelin doxorubicin
    T70775139570-93-7
    Zoptarelin doxorubicin, also known as AEZS-108, is an LHRH agonist. Zoptarelin doxorubicin is a peptide agonist of the gonadotropin releasing hormone-1 receptor (GnRH-1R) that is conjugated to the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Zoptarelin doxorubicin binds to GnRH-1Rs, which may be highly expressed on endometrial and ovarian tumor cell membrane surfaces, and is internalized. Once inside the cell, the doxorubicin moiety of this agent intercalates into DNA and inhibits the topoisomerase II activity, which may result in the inhibition of tumor cell DNA replication and tumor cell proliferation
    • $3,170
    10-14 weeks
    Size
    QTY
  • LY 202769
    T70777139543-40-1
    LY 202769 is a cholecystokinin-B antagonist.
    • $1,520
    6-8 weeks
    Size
    QTY